Redx Pharma

Redx Pharma

Signal active

Organization

Contact Information

Overview

Redx Pharma is a drug discovery and development company formed in 2010. It is focused on improving the characteristics of existing drug classes to create best-in-class new drugs in the areas of cancer, infection and autoimmune disease. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS.

Redx Pharma has three subsidiaries: Redx Oncology Ltd launched in April 2012, Redx Anti-Infectives Ltd launched in April 2013 and Redx Immunology Ltd launched in May 2015.

About

Industries

Biotechnology, Health Care, Pharmaceutical, Medical

Founded

2010

Employees

51-100

Headquarters locations

Europe

Social

N/A

Profile Resume

Redx Pharma headquartered in Europe, operates in the Biotechnology, Health Care, Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $13.2B in funding across 128 round(s). With a team of 51-100 employees, Redx Pharma is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Redx Pharma, raised $1.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Richard Armer

Richard Armer

CSO

imagePlace Lisa LM Anson

Lisa LM Anson

Chief Executive Officer

Funding Rounds

Funding rounds

8

Investors

1

Lead Investors

0

Total Funding Amount

$103.1M

Details

0

Redx Pharma has raised a total of $103.1M in funding over 0 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor

Investors

Redx Pharma is funded by 12 investors.

Investor NameLead InvestorFunding RoundPartners
Redx Pharma-FUNDING ROUND - Redx Pharmaundefined
Acceleris Capital-FUNDING ROUND - Acceleris Capitalundefined
Redx Pharma-FUNDING ROUND - Redx Pharma1.0M
CARB-X-FUNDING ROUND - CARB-X1.0M

Recent Activity

There is no recent news or activity for this profile.